Answer
VPRIV (velaglucerase alfa) is contraindicated in patients with hypersensitivity to velaglucerase alfa or any excipient listed in section 6.1.
Sources for this answer
- VPRIV 400 Units powder for solution for infusionTakeda UK Ltd · emc · SmPC §4.3 Contraindications · Version 21Document updated
Sources checked